AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 141 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,748,000 | +137.1% | 96,044 | +29.5% | 0.01% | +150.0% |
| Q4 2018 | $1,581,000 | -69.6% | 74,143 | -43.5% | 0.00% | -33.3% |
| Q3 2018 | $5,200,000 | +112.0% | 131,340 | +104.6% | 0.00% | 0.0% |
| Q2 2018 | $2,453,000 | +145.1% | 64,200 | +92.7% | 0.00% | +200.0% |
| Q1 2018 | $1,001,000 | +5.6% | 33,324 | +9.8% | 0.00% | 0.0% |
| Q4 2017 | $948,000 | +25.7% | 30,347 | +12.7% | 0.00% | 0.0% |
| Q3 2017 | $754,000 | +46.4% | 26,926 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $515,000 | +395.2% | 26,926 | +342.5% | 0.00% | – |
| Q1 2017 | $104,000 | -6.3% | 6,085 | 0.0% | 0.00% | – |
| Q4 2016 | $111,000 | +2.8% | 6,085 | 0.0% | 0.00% | – |
| Q3 2016 | $108,000 | – | 6,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |